phenformin has been researched along with Carcinoma, Pancreatic Ductal in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdel Hadi, N; Borge, L; Carrier, A; Cormareche, L; Diémé, B; Dou, S; Dusetti, N; El Kaoutari, A; Garcia, J; Gayet, O; Gicquel, T; Iovanna, J; Lac, S; Masoud, R; Pasquier, E; Reyes-Castellanos, G; Shintu, L; Tranchida, F | 1 |
| Han, SS; Hong, EK; Jang, H; Jeon, Y; Kim, HY; Kim, SY; Lee, H; Lee, JS; Lee, WJ; Park, SJ; Song, J; Woo, SM | 1 |
2 other study(ies) available for phenformin and Carcinoma, Pancreatic Ductal
| Article | Year |
|---|---|
Targeting Mitochondrial Complex I Overcomes Chemoresistance in High OXPHOS Pancreatic Cancer.
Topics: Animals; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Proliferation; Cell Respiration; Deoxycytidine; Drug Resistance, Neoplasm; Electron Transport Complex I; Female; Gemcitabine; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Nude; Mitochondria; Oxidative Phosphorylation; Pancreatic Neoplasms; PC-3 Cells; Phenformin; Xenograft Model Antitumor Assays | 2020 |
Overall survival of pancreatic ductal adenocarcinoma is doubled by
Topics: Aldehyde Dehydrogenase; Aldehydes; Animals; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Movement; Cell Proliferation; Gene Expression Regulation, Neoplastic; Gossypol; Homeodomain Proteins; Humans; Lipid Peroxidation; Mice; Mice, Knockout; Mice, Nude; Oxidative Phosphorylation; Pancreatic Neoplasms; Phenformin; Proto-Oncogene Proteins p21(ras); Signal Transduction; Survival Analysis; Trans-Activators; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays | 2021 |